Showing results (111-120 of 285) with videos related to
Sort By:
Pageof 29
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 11, 2020
Preliminary Clinical and Molecular Analysis Results From a Single-Arm Phase 2 Trial of Brigatinib in Patients With Disease Progression After Next-Generation ALK Tyrosine Kinase Inhibitors in Advanced ALK+ NSCLCThomas E Stinchcombe, Robert C Doebele, Xiaofei Wang, et al.Cancer|December 13, 2006
Venous thromboembolism occurs infrequently in meningioma patients receiving combined modality prophylaxisDavid E Gerber, Jodi B Segal, Amandeep Salhotra, et al.Journal of Oncology Practice|June 18, 2019
Reducing Hospitalizations: Institution of Outpatient Infusional EPOCH-Based Chemotherapy at a Safety Net HospitalNeil Keshvani, Mary Hon, Arjun Gupta, et al.Contemporary Clinical Trials Communications|September 17, 2025
Design and refinement of a clinical trial staffing model within the evolving landscape of oncology clinical trialsEllen Siglinsky, Hannah Phan, Silviya Meletath, et al.Journal of Biomedical Materials Research. Part A|September 3, 2011
A novel polymer gel for the delivery of local therapies to intracranial tumors: In vivo safety evaluationDavid E Gerber, Gary L Gallia, Betty M Tyler, et al.Plos One|April 10, 2020
Increased reporting but decreased mortality associated with adverse events in patients undergoing lung cancer surgery: Competing forces in an era of heightened focus on care quality?Mitchell S von Itzstein, Arjun Gupta, Kemp H Kernstine, et al.JAMA Oncology|July 8, 2021
Application of Information Technology to Clinical Trial Evaluation and Enrollment: A ReviewMitchell S von Itzstein, Melanie Hullings, Helen Mayo, et al.JAMA Oncology|August 4, 2022
A New Approach to Simplifying and Harmonizing Cancer Clinical Trials-Standardizing Eligibility CriteriaDavid E Gerber, Harpreet Singh, Erin Larkins, et al.Clinical Lung Cancer|November 30, 2019
QTc Interval-Prolonging Medications Among Patients With Lung Cancer: Implications for Clinical Trial Eligibility and Clinical CareTri Le, Hui Yang, Sawsan Rashdan, et al.Blood|May 16, 2008
The incidence of and risk factors for venous thromboembolism (VTE) and bleeding among 1514 patients undergoing hematopoietic stem cell transplantation: implications for VTE preventionDavid E Gerber, Jodi B Segal, M Yair Levy, et al.Pageof 29